BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1173@pharmaconomics
DTSTAMP:20260707T034932Z
DTSTART;VALUE=DATE:20260510
DTEND;VALUE=DATE:20260511
SUMMARY:ARGX PDUFA — Efgartigimod
DESCRIPTION:The FDA's approval decision on Efgartigimod for CIDP is due May 10\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1697862/000162828026031739/argxq1slides.htm\n\nTrack it: https://www.pharmaconomics.com/e/1173
URL:https://www.pharmaconomics.com/e/1173
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ARGX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR